Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Columbia University
Weill Medical College of Cornell University
UNC Lineberger Comprehensive Cancer Center
AIDS Malignancy Consortium
Duke University
UNC Lineberger Comprehensive Cancer Center
AIDS Malignancy Consortium
Duke University
AIDS Malignancy Consortium
AIDS Malignancy Consortium
ANRS, Emerging Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
AIDS Malignancy Consortium
Antiva Biosciences